Gene Y Im, MD, FAASLD

Description

Dr. Gene Im is a transplant hepatologist and the Director of the Alcohol Liver Program at Columbia known as ADAPT (Advanced inter-Disciplinary Alcohol liver Program and Treatment), a patient-centered, integrated care and research program for patients with alcohol-associated liver disease (ALD). ADAPT is one of only a few integrated ALD clinics in the country where single-visit expertise is provided with a hepatologist, psychiatrist and certified counselor. Dr. Im is an internationally recognized expert in ALD, including alcohol-associated hepatitis and liver transplantation. He has co-authored several practice-changing articles, including the 2019 ALD Practice Guidance from AASLD, the 2024 MetALD Expert Position Statement, and the first experience of early liver transplantation for alcohol-associated hepatitis in North America. His work has been featured in CNN, the New York Times and the New England Journal of Medicine. He is a former member of the ACCELERATE consortium and the founder of ALD-CORE, a multicenter collaborative focusing on ALD outcomes research. Dr. Im is serving as Chair of the AASLD ALD Special Interest Group and serves on the Editorial Board for the journal Liver Transplantation. He is also the founder of ALD-ALLY (Alcohol-associated Liver Disease patients deserve ALcohol LiteracY), an annual conference focused on actionable initiatives for advancing the science and care of patients with alcohol use disorder and ALD (www.ald-ally.com) Dr. Im is an Associate Professor of Medicine in the Center for Liver Disease and Transplantation and Division of Digestive and Liver Diseases at Columbia University.